KD Logo

Director Lonial Sagar sale 5,000 shares of TG Therapeutics Inc [TGTX]

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. TG Therapeutics Inc shares valued at $79,675 were sold by Lonial Sagar on Mar 13 ’24. At $15.94 per share, Lonial Sagar sold 5,000 shares. The insider’s holdings dropped to 108,878 shares worth approximately $1.84 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Charney Laurence N sold 22,000 shares, netting a total of over 351,340 in proceeds. Following the sale of shares at $15.97 each, the insider now holds 215,229 shares.

Before that, Charney Laurence N had sold 17,500 shares from its account. In a trade valued at $333,025, the Director traded TG Therapeutics Inc shares for $19.03 each. Upon closing the transaction, the insider’s holdings decreased to 17,500 shares, worth approximately $4.01 million.

As published in a research note from Goldman on August 02, 2023, TG Therapeutics Inc [TGTX] has been rated up from a Sell to a Neutral and the price target has been revised to $12 from $16. As of May 20, 2022, BofA Securities has initiated its “an Underperform” rating for TGTX. Earlier on February 23, 2022, B. Riley Securities resumed its rating. Their recommendation was “a Buy” for TGTX stock.

Analyzing TGTX Stock Performance

During the last five days, there has been a surge of approximately 3.05%. Over the course of the year, TG Therapeutics Inc shares have dropped approximately -0.94%. Shares of the company reached a 52-week high of $22.67 on 01/10/24 and a 52-week low of $12.84 on 02/21/24. A 50-day SMA is recorded $15.40, while a 200-day SMA reached $13.25. Nevertheless, trading volume fell to 2.68 million shares from 4.23 million shares the previous day.

Support And Resistance Levels for TG Therapeutics Inc (TGTX)

According to the 24-hour chart, there is a support level at 16.72, which, if violated, would cause prices to drop to 16.52. In the upper region, resistance lies at 17.23. The next price resistance is at 17.54. RSI (Relative Strength Index) is 66.96 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.87, which suggests the price will increase in the coming days. Percent R is at 21.30%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Most Popular